Patient and Treatment Characteristics of New Users of SGLT-2i and/or ARNi in HFrEF Patients With and Without T2DM: A Real-World Data Analysis Based on German Claims Data.
Konferenzabstract für ISPOR, veröffentlicht in "Value in Health 2024"
Autor:innen
U., Lehrke, M., Stuermlinger, A., Bucksch, K., Kolb, N., Kossack, N. Rauch-Kröhnert
